GRN No. 274
|Substance:||Branching glycosyltransferase enzyme preparation from Bacillus subtilis expressing a branching glycosyltransferase gene from Rhodothermus obamensis|
|Intended Use:||As an enzyme in the starch industry to obtain dextrins with improved physical properties, such as higher solubility, lower viscosity, and reduced retrogradation|
Novozymes North America, Inc.
77 Perry Chapel Church Rd.
Franklinton, NC 27525
|Date of filing:||Dec 30, 2008|
|GRAS Notice (releasable information):||274|
|Date of closure / FDA's Letter:||
Jun 25, 2009
FDA has no questions